Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
Insulet Corp PODD
News
Insulet's Omnipod 5 Gets FDA Clearance for Use by Type 2 Diabetes Patients
Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
Eli Lilly's Mounjaro cuts risk of developing Type 2 diabetes, study finds
Insulet to Present at Upcoming Investor Conferences
Insulet Celebrates Grand Opening of 400,000-square-foot Manufacturing Facility in Malaysia
Insulet Reports Second Quarter 2024 Revenue Increase of 23% Year-Over-Year
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
Worried you missed the Nvidia bandwagon? Here are some alternative stock picks.
Worried you missed the Nvidia bandwagon? Here -2-
Diabetes stocks are surprise winners from Novo Nordisk's Wegovy study, analysts say
Insulet shares rebound after results top estimates
Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts say
These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say
Insulet CFO McMillan Steps Down to Join 3M Health Care Business
Insulet shares rise as analysts say weight-loss drug fears may be overblown
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.
These 20 growth stocks are worth considering on a pullback, says Citi
United States